Cooper Companies COO
NASDAQ COO
$53.91 -0.26 (-0.48%)
At close: Sep 11, 2026 · 4:00 PM EDT

Cooper Companies (COO) Other Non-Current Assets (2009 - 2026)

Cooper Companies (COO) posted Other Non-Current Assets of $672.8 million for Q2 2026, down 2.27% on a QoQ basis from $688.4 million in Q1 2026, and up 2.09% year-over-year from $659.0 million in Q2 2025.

Analysis

Cooper Companies (COO) Other Non-Current Assets (2009 - 2026) Analysis & Trends

Cooper Companies has reported Other Non-Current Assets for 18 years, with the latest figure at $672.8 million in Q2 2026.

  • On a quarterly basis, Other Non-Current Assets rose 2.09% year-over-year to $672.8 million in Q2 2026; TTM through Apr 2026 was $672.8 million, a 2.09% increase from a year earlier, with the FY2025 full-year figure at $689.2 million, up 4.33% from the prior year.
  • Other Non-Current Assets was $672.8 million for Q2 2026 at Cooper Companies, down from $688.4 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $689.2 million in Q4 2025, with the low at $169.0 million in Q1 2022.
  • Average Other Non-Current Assets over 5 years is $575.6 million, with a median of $632.6 million recorded in 2023.
  • The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets soared 236.57% in 2023, then retreated 1.08% in 2024.
  • Over 5 years, Other Non-Current Assets stood at $587.9 million in 2022, then advanced by 8.37% to $637.1 million in 2023, then advanced by 3.69% to $660.6 million in 2024, then rose by 4.33% to $689.2 million in 2025, then fell by 2.38% to $672.8 million in 2026.
  • The last three Other Non-Current Assets figures came in at $672.8 million (Q2 2026), $688.4 million (Q1 2026), and $689.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Abbott Laboratories 178.01 Bn 172.41 Bn 7.27 Bn -
2 Intuitive Surgical 131.29 Bn 126.08 Bn 1.96 Bn -
3 Medtronic 116.38 Bn 107.56 Bn 6.34 Bn 4.32 Bn
4 Stryker 106.01 Bn 102.53 Bn 4.50 Bn 3.23 Bn
5 Boston Scientific 63.40 Bn 62.86 Bn 3.85 Bn 45.22 Bn
6 Edwards Lifesciences 48.89 Bn 44.64 Bn 1.35 Bn 616.40 Mn
7 Alcon 32.59 Bn 31.13 Bn 1.68 Bn 434.00 Mn
8 Dexcom 31.84 Bn 29.89 Bn 830.00 Mn 273.70 Mn
9 Steris 20.61 Bn 20.13 Bn 684.20 Mn 215.10 Mn
10 Cooper Companies 10.51 Bn 10.37 Bn 735.40 Mn 672.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 672.80 Mn
Jan 31, 2026 688.40 Mn
Oct 31, 2025 689.20 Mn
Jul 31, 2025 653.30 Mn
Apr 30, 2025 659.00 Mn
Jan 31, 2025 663.70 Mn
Oct 31, 2024 660.60 Mn
Jul 31, 2024 621.40 Mn
Apr 30, 2024 637.20 Mn
Jan 31, 2024 616.90 Mn
Oct 31, 2023 637.10 Mn
Jul 31, 2023 628.20 Mn
Apr 30, 2023 584.80 Mn
Jan 31, 2023 568.80 Mn
Oct 31, 2022 587.90 Mn
Jul 31, 2022 306.00 Mn
Apr 30, 2022 317.40 Mn
Jan 31, 2022 169.00 Mn
Oct 31, 2021 401.20 Mn
Jul 31, 2021 117.20 Mn